The effectiveness of antiviral and immune therapies was inconsistent in most cases of COVID-19. |
To date, remdesivir, dexamethasone, and baricitinib represent the best therapeutic option. |
The promising results of efficacy of anakinra need confirmation by the ongoing RCTs. |